
CerebraAI
AI-driven medical software for early stroke detection and automated non-contrast CT analysis.
- Industry
- HealthTech, AI / ML, MedTech
- Founded
- 2018
- Team size
- 10-49 people
- Based in
- Kazakhstan
Verified revenue: not connected yet
Is CerebraAI yours? Claim this page and connect Stripe, the App Store or Google Play: your MRR and growth show here, read straight from the source.
About
Revolutionizing emergency medicine, this MedTech startup provides an AI-powered platform for rapid and accurate stroke diagnosis. The software analyzes non-contrast CT scans in under two minutes, detecting early signs of ischemic and hemorrhagic strokes that might be invisible to the human eye. By automating ASPECTS scoring and large vessel occlusion detection, the service empowers neurologists to make life-saving decisions during the critical "golden hour," significantly improving patient outcomes.
The infrastructure is trusted by over 50 hospitals and has processed more than 150,000 patients across Central Asia and beyond. Recognized by Stanford StartX and Berkeley Health Engine, the venture integrates seamlessly into clinical workflows via desktop and mobile apps. With headquarters in Palo Alto, the platform bridges the gap between advanced neuroradiology and emergency care, ensuring high-quality diagnostics are available when every second counts.
Funding
- Total raised
- $5,100,000
- Last round
- Seed · 25 November 2023
Team
- Doszhan Zhussupov, CEO & Founder (Founder)
Audience
Followers on social networks
Profile data from Stanbase.